These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2958098)
21. [Phenobarbital-type induction of cytochrome P-450 in liver microsomes by perfluorodecalin]. Grishanova AIu; Obraztsov VV; Shekhtman DG; Liakhovich VV Biokhimiia; 1987 Jul; 52(7):1138-43. PubMed ID: 3663750 [TBL] [Abstract][Full Text] [Related]
22. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats. López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788 [TBL] [Abstract][Full Text] [Related]
23. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus. Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532 [TBL] [Abstract][Full Text] [Related]
24. The effect of vanadate upon the expression of phenylalanine hydroxylase in streptozotocin-diabetic rat liver. Green AK; McDowall IL; Richardson SC; Fisher MJ Biochim Biophys Acta; 1992 Oct; 1180(1):21-7. PubMed ID: 1382616 [TBL] [Abstract][Full Text] [Related]
25. Effects of a hormone-supplemented medium on cytochrome P-450 content and mono-oxygenase activities of rat hepatocytes in primary culture. Dickins M; Peterson RE Biochem Pharmacol; 1980 May; 29(9):1231-8. PubMed ID: 7397008 [No Abstract] [Full Text] [Related]
26. Substrate specificity of the mouse skin mixed-function oxidase system. Rettie AE; Williams FM; Rawlins MD Xenobiotica; 1986 Mar; 16(3):205-11. PubMed ID: 3705617 [TBL] [Abstract][Full Text] [Related]
27. Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. Barnett CR; Flatt PR; Ioannides C J Biochem Toxicol; 1994 Apr; 9(2):63-9. PubMed ID: 8071947 [TBL] [Abstract][Full Text] [Related]
28. Control of glycogen synthase and phosphorylase in hepatocytes from diabetic rats. Effects of glucagon, vasopressin, and vanadate. Rodríguez-Gil JE; Gómez-Foix AM; Ariño J; Guinovart JJ; Bosch F Diabetes; 1989 Jun; 38(6):793-8. PubMed ID: 2498142 [TBL] [Abstract][Full Text] [Related]
29. The inducing and inhibiting effects of sodium valproate in vivo on the biotransformation systems of xenobiotics in isolated rat hepatocytes. Rogiers V; Vandenberghe Y; Callaerts A; Sonck W; Maes V; Vercruysse A Xenobiotica; 1988 Jun; 18(6):665-73. PubMed ID: 3138827 [TBL] [Abstract][Full Text] [Related]
30. Regulation of hepatic glutaminase in the streptozotocin-induced diabetic rat. Squires SA; Ewart HS; McCarthy C; Brosnan ME; Brosnan JT Diabetes; 1997 Dec; 46(12):1945-9. PubMed ID: 9392478 [TBL] [Abstract][Full Text] [Related]
31. Hepatic metabolism of vitamin D3 in streptozotocin-induced diabetic rat. Sulimovici S; Roginsky MS Acta Endocrinol (Copenh); 1980 Mar; 93(3):346-50. PubMed ID: 6246702 [TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709 [TBL] [Abstract][Full Text] [Related]
33. Hepatic glucose-6-phosphatase activities and correlated ultrastructural alterations in hepatocytes of diabetic rats. Garfield SA; Cardell RR Diabetes; 1979 Jul; 28(7):664-79. PubMed ID: 221299 [TBL] [Abstract][Full Text] [Related]
34. Aldrin epoxidase in liver and small intestine of rat and Japanese quail. Riviere JL; Bach J Bull Environ Contam Toxicol; 1979 Mar; 21(4-5):498-501. PubMed ID: 444742 [No Abstract] [Full Text] [Related]
35. Aldrin epoxidation in flathead mullet (Mugil cephalus): possible involvement of CYP1A and CYP3A. Bozcaarmutlu A; Turna S; Sapmaz C; Arinc E; Yenisoy-Karakaş S J Biochem Mol Toxicol; 2014 Jun; 28(6):271-80. PubMed ID: 24756956 [TBL] [Abstract][Full Text] [Related]
36. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450. Past MR; Cook DE Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187 [TBL] [Abstract][Full Text] [Related]
37. Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats. Sindhu RK; Koo JR; Sindhu KK; Ehdaie A; Farmand F; Roberts CK Free Radic Res; 2006 Sep; 40(9):921-8. PubMed ID: 17015271 [TBL] [Abstract][Full Text] [Related]
38. Alterations in hepatic microsomal cytochrome P-450 hemeproteins in diabetic rats. Past MR; Cook DE Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):329-37. PubMed ID: 6768119 [TBL] [Abstract][Full Text] [Related]
39. Role of ketone bodies in the diabetes-induced changes in hepatic mixed-function oxidase activities. Barnett CR; Flatt PR; Ioannides C Biochim Biophys Acta; 1988 Nov; 967(2):250-4. PubMed ID: 3191152 [TBL] [Abstract][Full Text] [Related]
40. Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats. Donahue BS; Skottner-Lundin A; Morgan ET Endocrinology; 1991 Apr; 128(4):2065-76. PubMed ID: 1706265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]